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Much emphasis has been placed recently on the repair of degenerate discs using implanted cells, such as disc cells or bone marrow
derived mesenchymal stem cells (MSCs). This study examines the temporal response of bovine and human nucleus pulposus
(NP) cells and MSCs cultured in monolayer following exposure to altered levels of glucose (0, 3.15, and 4.5 g/L) and foetal bovine
serum (0, 10, and 20%) using an automated time-lapse imaging system. NP cells were also exposed to the cell death inducers,
hydrogen peroxide and staurosporine, in comparison to serum starvation. We have demonstrated that human NP cells show an
initial “shock” response to reduced nutrition (glucose). However, as time progresses, NP cells supplemented with serum recover
with minimal evidence of cell death. Human NP cells show no evidence of proliferation in response to nutrient supplementation,
whereas MSCs showed greater response to increased nutrition. When specifically inducing NP cell death with hydrogen peroxide
and staurosporine, as expected, the cell number declined. These results support the concept that implanted NP cells or MSCs may
be capable of survival in the nutrient-poor environment of the degenerate human disc, which has important clinical implications
for the development of IVD cell therapies.
1. Introduction
Degeneration of the intervertebral disc (IVD), which is often
associated with low back pain, is attributed to altered cell
activity and a reduced number of healthy functioning cells
within the extracellular matrix [1, 2]. Many factors have been
reported which impact cell viability and metabolism, includ-
ing mechanical loading, osmolarity, and reduced nutrient
levels [3–5]. This reduction in nutrient availability such as
levels of glucose, for example, to cells in the degenerate IVD
is thought to occur via occlusion of one of the main nutrient
pathways, through the cartilaginous and vertebral endplate
due to increased calcification [6–8]. Degeneration appears to
commence and be predominant in the central region of the
disc, the nucleus pulposus (NP), and within the first decade
of life in humans [9].
Autologous chondrocyte implantation (ACI) has been
in use in the clinic for several years for the treatment of
cartilage defects and early osteoarthritis [10–12]. Studies
have demonstrated that the implantation of autologous disc
cells into IVD defects may have similar potential for some
degree of tissue regeneration, as shown in animal models
of degenerate disc disease [13, 14]. IVD repair following the
implantation of cultured bonemarrow derived mesenchymal
stem cells (MSCs) in animal studies has also been reported,
though the mode of action remains unclear (i.e., whether
the cells act via a paracrine effect by direct synthesis of
matrix). Certainly implanted MSCs have been retained in
the IVD tissue and remained viable for up to 6 months [14–
18]. Following the reported successes in animal studies, these
techniques have started to be translated into clinical trials
in humans, where autologous IVD cells or MSCs have been
implanted for tissue regeneration [19]. The most promising
reported clinical study of cell therapy for disc repair describes
a reduction in pain and return of IVD hydration to more
normal levels in some patients, following autologous IVD cell
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implantation [20], although long-term follow-up studies are
lacking.
The development of cell transplantation techniques for
the repair of degenerate IVD tissue clearly has some exciting
potential. However, the nutrient-poor environment of degen-
erate IVD tissue could be detrimental to the implanted cells.
For example, following implantation, cell populations may
not receive the nutrient support required for any reparative
function, or even for their survival. In addition, there is some
suggestion that MSCs may be less suitable for implantation
into degenerate IVD tissue as they are less adapted to survival
in nutrient-poor environments in comparison to native IVD
cells [21]. Hence, a suitable cell source needs to be identified
which will be able to survive and repair the damaged tissue
under nutrient-poor conditions.
In this study, we assessed the response of IVD cells and
MSCs to reduced nutrient levels in vitro using a temporal live
cell imaging and analysis system. In addition to identifying
a cell population that can survive nutrient deprivation, we
aimed to investigate the environmental insults required to
induce apoptosis, which is reported in cells throughout
degenerate IVD tissue [22–25]. In 2009, a technique of
automated microscopic time-lapse imaging technology was
reported for tracking rabbit notochordal and chondrocyte-
like cells in culture [26]. We report here on a similar method
for longitudinal automated quantitative analysis of cell cul-
tures which we have used to examine the response of NP
cells (both human and bovine) and human MSCs to altered
nutrient levels, utilising time-lapse imaging to quantify cell
size and viability, before further assessing induction of cell
death.
2. Materials and Methods
2.1. Bovine and Human NP and MSC Source. NP cells were
isolated from bovine caudal intervertebral discs obtained
within 2 hours of death from a local abattoir. In addition,
with local research ethical committee approval and informed
consent, humanNPcellswere isolated fromfive patients (four
males and one female, aged 35±7.5 years) undergoing routine
lumbar vertebral fusion procedures, for the treatment of low
back pain. MSCs (from bone marrow aspirates or iliac crest
bone chip) were also obtained from two of these patients
(both males, aged 36 and 40 years), plus a further female
patient (aged 56 years).
2.2. Bovine NP Cell Isolation and Culture. NP cells were
isolated from the caudal discs of 3 adult cows.The central NP
tissuewas dissected out and the three upper discswere pooled
from each animal. Tissue was finely minced and digested
overnight with collagenase XI (0.8mg/mL (≥960CDU/mL))
in DMEM/F12 medium (both from Sigma-Aldrich, St. Louis,
USA) at 37∘C. Cells were then maintained in culture at
5000 cells/cm2 in DMEM/F12 culture medium (Life Tech-
nologies, Paisley, UK) routinely supplemented with 10% (v/v)
foetal bovine serum (FBS) (PAA, Yeovil, UK), 50 𝜇g/mL
ascorbic acid (Sigma-Aldrich), 0.5% (v/v) gentamicin (Life
Technologies), and 0.05% fungizone (Life Technologies),
at 37∘C in a humidified atmosphere of 5% CO
2
. Cells were
passaged as standard by trypsinisation upon reaching 80%
confluence and used at passage 4 or 5.
2.3. Human NP Cell Isolation and Culture. Freshly excised
human NP tissue (identified macroscopically and confirmed
microscopically) was dissected from the IVD tissue obtained
at surgery. Cells were isolated andmaintained in the sameway
as the bovine NP cells and used at passages 2–4.
2.4. Human MSC Isolation and Culture. Iliac crest bone
marrow aspirates or iliac crest bone chip washouts were
centrifuged over Lymphoprep (Fresenius Kabi Ltd., Runcorn,
UK) for 20 minutes at 900 g to isolate the mononuclear cells
via a density gradient. Harvested mononuclear cells were
then centrifuged for 10 minutes at 750 g and a cell count was
performed.Themononuclear cells were plated at 20× 106 cells
per 75 cm2 tissue culture flask, in DMEM/F12 supplemented
with 20% (v/v) FBS (Life Technologies) and 1% (v/v) of
10,000 units/ml penicillin and 10,000 mg/ml streptomycin
(Life Technologies). After 24 hours, nonadherent cells were
removed and the remaining adherent cells were routinely
cultured at 5000 cells/cm2 inDMEM/F12, supplementedwith
10% (v/v) FBS (Life Technologies) and 1% (v/v) penicillin
and streptomycin (Life Technologies). Cells were passaged as
standard by trypsinisation upon reaching 80% confluence.
2.5. Nutrition Response Assays. Human and bovine NP cells
and human MSCs were seeded into 24-well tissue culture
plates at 5,000 or 10,000 cells/cm2 and maintained at 37∘C
in a humidified atmosphere of 5% CO
2
, overnight, to allow
cell adherence. Immediately prior to imaging, routine culture
medium was removed from each well and replaced with
“assay” medium in triplicate. Eight assay medium types were
made using combinations of 0%, 10%, and 20% (v/v) FBS as
well as no glucose, moderate (standard) glucose (3.15 g/L),
and high glucose (4.5 g/L) medium (Life Technologies).
2.6. Induction of Bovine NP Cell Death and Apoptosis. Bovine
NP cells were seeded into tissue culture plates and allowed
to adhere overnight. The cells were then monitored for
18 hours following treatment with one of three classical
cell death inducers: either introduction of culture medium
(i) supplemented with 750𝜇M hydrogen peroxide (Sigma-
Aldrich) or (ii) 2 𝜇M staurosporine (Sigma-Aldrich) or a
more physiological insult of serum deprivation (with 0%
FBS). A control culture was included of cells grown in
standard culture conditions of culture medium containing
10% FBS culture medium and 3.15 g/L glucose.
2.7. Automated Longitudinal Image Capture andQuantitation.
Cellular responses to changes in the glucose or FBS content
in medium and cell death induction were monitored by
the collection of a series of digital images using the Cell-
IQ Analyser (V2) automated image capture system (CM
Technologies Oy, Tampere, Finland). In this closed system,
cells were maintained in an optimised environment of 37∘C
and premixed 5% CO
2
with air (BOCGases, Guildford, UK).
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Figure 1: Sample library generated using the Cell-IQ® Analyser software. (a) Samples within the library are divided into three categories:
live, phase-bright, and debris. Examples are added to the library to teach the software into which category a cell should fall. (b) Transition of
human nucleus pulposus cells from a phase-bright category to a live, fibroblast category, over 48 hours.
The premixed gas was delivered directly to the culture plates
through a patented perfusion lid, designed to allow the gas to
be delivered under a stop-flow regime, providing an optimal
uniform concentration of gas across the entire plate.
Following the appropriate medium application, at least
one region of interest (approximately 975 × 730 𝜇m) was
selected per well and phase contrast images were collected
every 20–30 minutes for 48 hours. Images were captured
using a 20𝜇mZ-stack. By creating a library of sample images,
the Cell-IQ Analyser software was taught to identify cells
as live or phase-bright and also to dismiss debris within
the region of interest (Figure 1(a)). The total cell area, using
threshold gating analyses at each individual time point (for
each image), was also determined, in each culture condition
tested. This provided the mean area coverage (total cells
area/cell number). Temporal trends for live cell number (the
sum of both live and phase-bright cell classes) and area were
compared for each culture condition over 48 hours. These
parameters were then statistically compared at the final time
point.
2.8. Statistical Analysis. All culture conditions were per-
formed in triplicate for each cell population. All statisti-
cal analyses were performed using Analyse-It® software for
Microsoft Excel. The Anderson-Darling test for normal-
ity was used to assess data. When normally distributed,
differences were investigated using Student’s 𝑡-tests whilst
Mann-Whitney tests were used for non-normally distributed
data. Statistical significance was taken at 𝑝 < 0.05. Data
presented are means ± standard error of the mean (SEM).
3. Results
3.1. Temporal Responses to Nutrient Deprivation
3.1.1. BovineNPCell Number. Due to variation in the cell den-
sity in each region of interest at the start of the image capture,
live cell counts per image were expressed as a percentage of
the initial cell count; thus, all cultures began at 100%. Most of
the growth conditions tested produced an increase in live cell
number over time, except for cultures without FBS or glucose
and those with high levels of glucose, which showed amarked
reduction in live cell number over the 48 hours, reducing to
50.17, 85.87, and 85.05% (Figure 2(a)).
At the final time point, moderate glucose supplementa-
tion to medium containing no FBS produced significantly
more live cells than those cultures without FBS or glucose
(179.26 versus 50.17%, resp.; 𝑝 < 0.01, Figure 2(b1)). Interest-
ingly, the application of high glucose concentrations seemed
to have little effect on live cell number in either the presence
or the absence of FBS (85.05 compared to 85.87%, resp.).
The addition of FBS to medium containing no glucose
significantly enhanced live cell numbers compared to cultures
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Figure 2: Monitoring the response of bovine NP cell cultures to changes in FBS and glucose concentration over 48 hours. (a) Temporal
analysis for live cell number, expressed as the percentage of the initial live cell number. (b) Live cell number, expressed as a percentage of the
initial live cell number at the final time point (±SEM), comparing FBS levels within glucose subgroup (b1) and comparing glucose levels within
FBS subgroup (b2). (c) Temporal analysis for area coverage normalised to live cell number. (d) Cell area, normalised to live cell number, at
the final time point (±SEM), comparing FBS levels within glucose subgroup (d1) and comparing glucose levels within FBS subgroup (d2). ∗
represents a statistically significant difference of 𝑝 < 0.05.
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in medium containing no FBS or glucose (259.43 versus
50.17%, resp.; 𝑝 < 0.01). Whilst the addition of 10% or 20%
FBS to medium containing moderate glucose produced a
greater percentage of live cells than those without FBS, the
difference was only significant for 20% FBS (403.59, 370.69,
and 179.26%, resp.; 𝑝 = 0.03, Figure 2(b1)).
3.1.2. Bovine NP Cell Area. Over the 48-hour time period
assessed, cell area (normalised to live cell number) was
reasonably constant (Figure 2(c)). At the final time point,
supplementation of glucose to medium containing no FBS
produced a significantly larger mean cell area size (1947.53
and 1809.13 compared to 1395.63𝜇m2, resp.; 𝑝 < 0.01,
Figure 2(d2)). When the medium contained FBS, the addi-
tion of glucose resulted in a reduced cell area (1585.08
compared to 2155.03 𝜇m2, resp.), whilst the supplementation
of FBS to medium containing no glucose produced a sig-
nificantly greater cell area compared to those cultures with
no FBS or glucose at all (2155.03 versus 1395.63 𝜇m2, resp.;
𝑝 < 0.05, Figure 2(d2)). In contrast, whenmedium contained
glucose, the addition of FBS led to a significant reduction in
mean cell area (1585.08 versus 1947.53 𝜇m2, resp.; 𝑝 < 0.05,
Figure 2(d1)).
3.2. Human NP Cell and MSC Number. As with bovine
NP cells, live cell numbers of human NP cells and MSCs
were expressed as a percentage of initial live cell number.
Unlike the bovine NP cells, the human NP cells showed less
variation in cell number with each condition (Figure 3(a)).
However, at the end time point, those NP cells treated with
0% FBS and moderate glucose had a significantly greater
number of live cells than those treated with 10 or 20% FBS
and moderate glucose (128.44, 106.38, and 119.67%, resp.;
Figure 3(b1)) whilst those cells treated without FBS showed
significantly greater numbers of live cells when moderate
glucose was added, compared to without (128.44 versus
106.14%; Figure 3(b2)). The human MSCs were particularly
responsive to altered glucose and showed greater increases in
cell number compared to the human NP cells (Figure 3(c)).
For the MSCs treated with no glucose, the addition of FBS
resulted in significantly more live cells than those without
FBS (111.42, 114.55, and 93.89%, resp.; Figure 3(d1)). Further,
the concentration of glucose did not significantly alter the
live cell number for any of the FBS percentages investigated
(Figure 3(d2)).
In all of the conditions without glucose, at least some of
the NP cells at initial time points appeared semiadherent,
with rounded phase-bright morphologies. These cells we
believe are either dividing or dying as mitotic (dividing) and
early apoptotic cells both undergo the same morphological
changes of becoming rounded and phase-bright. At this
point, these cells are alive and will go on to divide or
enter apoptosis. Additionally, as observed in the current
study, this phase-bright morphology is part of a short-term
“shock response” to glucose deprivation. However, as time
progressed, in those cultures that had serum supplementation
at 10% (Figure 4(b)) or 20% (Figure 4(c)), these semiadhered
cells appeared to reattach and returned to a fibroblast-like
morphology. If you compare this change in cell morphology
to the original sample library (Figure 1(b)), it can be seen
how the cells switch categories throughout the time period
of the experiment. Cells that had neither serum nor glucose
remained in a semiadherent state during the 48 h tested
(Figure 4(a)), compared to control cultures supplemented
with 10% FBS and moderate glucose (standard NP culture
conditions), which maintained a fibroblast-like morphology
throughout (Figure 4(d)). No morphological changes like
these were seen in the cell populations supplemented with
glucose but no FBS.
3.3. Human NP Cell and MSC Cell Area. The human NP
cells showed little change in mean cell area over the 48-
hour time period for any condition tested, with the exception
of those cells treated with 10% FBS and moderate glucose
(Figure 5(a)). These cells remained consistently larger than
the others over the 48 hours. At the end time point, the cells
treatedwith 10%FBS andmoderate glucose were significantly
larger than those without glucose or FBS (12802.7 compared
to 7339.4 𝜇m2, resp.), whilst no other differences were seen
(Figure 5(b)). In contrast, the MSCs, treated with 0% FBS
and high glucose, had consistently lower mean cell areas,
compared to MSCs grown in other conditions, for the dura-
tion of the experiment. Those cells treated with 10% FBS had
smaller area coverage than those treatedwith 20%FBS, whilst
the presence of glucose made little difference. Interestingly,
the MSCs treated with 10% FBS but no glucose had the
largest cell area over the 48-hour experiment (Figure 5(c)).
Although these notable differences were mirrored at the end
time point, none of these were significant (Figure 5(d)). It is
noteworthy that there were no significant differences in the
parameters that we analysed (i.e., cell number expressed as a
percentage of the starting value or cell area normalised to live
cell number) when comparing the initial seeding densities of
each culture, that is, 5000 versus 10,000 cells per cm2 (data
not shown).
3.4. Temporal Response of Bovine NP Cells to Induction of Cell
Death and Apoptosis. NP cells in standard culture conditions
(10% FBS and moderate glucose) were used as controls for
normal cell growth and compared to those cells treated with
inducers of cell death and apoptosis. In control cultures,
cells were plastic adherent and fibroblast-like unless they are
dividing, in which case cells appeared rounded and phase-
bright (Figure 6(a)). Control cell numbers increased mod-
estly over the 18 hours tested, to approximately 110% of the
initial number seeded (Figure 6(e)). Generally, FBS-starved
cells appeared similarly spread and fibroblast-like, although
therewas little evidence of cell proliferation; this was reflected
in the cell numbers recorded, which remained constant
throughout the 18-hour experiment (Figures 6(b) and 6(e)).
In contrast, those cultures treated with staurosporine or
hydrogen peroxide (H
2
O
2
) contained few, if any, spread or
adhered cells; most cells appeared rounded or fragmented at
the 18-hour time point (Figures 6(c) and 6(d)) and the live cell
number markedly decreased. Cell number of H
2
O
2
treated
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Figure 3: Temporal analysis of number of human NP cells and MSCs in response to altered FBS and glucose concentration, over 48 hours.
Trends over 48 hours for human NP cells (a) and human MSCs (c) and at the end time point (±SEM) for human NP cells (b) and human
MSCs (d), comparing FBS levels within glucose subgroups ((b1) and (d1)) and comparing glucose levels within FBS subgroups ((b2) and
(d2)).
cultures decreasedmore rapidly in the first 3 hours compared
to staurosporine treated cells (Figure 6(e)). However, by the
final time point, there was no significant difference between
H
2
O
2
or staurosporine treatments (which were 28% and
27% of the initial live cell number, resp.; Figure 6(f)). Both
H
2
O
2
and staurosporine treatments resulted in significantly
reduced cell numbers at the 18-hour time point compared to
control cultures or those with no FBS (𝑝 < 0.05; Figure 6(f)).
Themean cell area remained fairly consistent over the 18-
hour experiment in all of the conditions tested. Cell areas
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Figure 4: Changes in human NP cellular morphology with time. (a) Cells treated with 0% FBS and no glucose appeared “phase-bright” and
semiadhered. This morphology showed no change over time, whereas cells treated with 10% FBS and no glucose (b) and 20% FBS with no
glucose (c) showed recovery from a rounded phase-bright morphology to flattened live fibroblast morphology during the 48 hours; (d) cells
treated with 10% FBS and moderate glucose were flattened and fibroblast-like and showed no discernible changes in morphology over time.
for cultures without FBS were slightly higher than controls,
whereas values for H
2
O
2
and staurosporine treated cultures
were lower than controls. Staurosporine treated cells had
significantly smaller cells compared to cells grown under any
other condition tested (𝑝 < 0.05; Figures 6(g) and 6(h)).
4. Discussion
Alterations of nutrition in the degenerate IVDmay influence
a cell therapy approach by dictating which cell type is able to
survive and restore disc function. The main aim of this study
was to examine the temporal response of NP cells and MSCs
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Figure 5: Temporal analysis of human NP cell and MSC area coverage in response to FBS and glucose concentration over 48 hours. Trends
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for (b) human NP cells and (d) human MSCs, comparing FBS levels within glucose subgroups ((b1) and (d1)) and comparing glucose levels
within FBS subgroups ((b2) and (d2)).
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Figure 6: The response of bovine NP cells to induction of cell death inducers over 18 hours. Representative phase contrast images following
18-hour exposure to 10% (a) or 0% (b) FBS with moderate glucose, (c) hydrogen peroxide, and (d) staurosporine. (e) Temporal analysis for
live cell number, expressed as percentage of the initial live cell number. (f) Live cell number, expressed as a percentage of the initial live cell
number at the final time point (±SEM). (g) Temporal analysis for area coverage normalised to live cell number. (h) Area coverage, normalised
to live cell number, at the final time point (±SEM).
10 Stem Cells International
(the two main types of cell proposed in the literature for
such a procedure) [13–18, 27, 28] to physiologically relevant
nutrition depletion in vitro. We approached the study in
a stepwise manner, first establishing methods (including
inducing apoptosis using the “classical” but not physiological
stimuli) on bovine NP cells, since this population can be
obtained as a more numerous and homogenous population
than from humans. We applied “classical” death inducing
agents to these, in addition to studying the influence of
nutrient depletion, both in human and in bovine cells, but at
slightly different time points.The levels of nutrients which the
cells were exposed to in these in vitro studies were taken from
levels that we have used previously and have published in the
literature [29]. There is of course some potential limitation
here as levels reported for the intervertebral disc have in
the main been obtained from either indirect measurements
or modelling, since actual direct in vivo measurements are
limited, particularly in normal human discs, as the methods
required to do this are invasive [30].
Firstly, we have shown that human MSCs appear to
be more sensitive to nutrient deprivation than human NP
cells. In the current study, medium containing no glucose
but supplemented with 10% FBS provided up to 0.5mM of
glucose. The critical threshold of glucose concentration for
NP cells, at which cell death occurs, is reported to be 0.5mM
[31], thus explaining the survival of NP cells in the low
glucose conditions tested in our study. MSCs, however, are
derived from a highly vascularised and hence nutrient rich
tissue (bone marrow) [32] and may require greater nutrition
for survival particularly as blood glucose concentration is
4–5.5mM [33]. Indeed, other similar immature mesenchy-
mal cells (intervertebral disc notochordal cells) have been
reported to require at least 1mM of glucose for normal
metabolism [34]. Further, in agreementwith previous studies,
we have demonstrated that FBS and glucose starvation had
a pronounced effect on bovine NP cell viability, causing a
reduction in live cells [5, 35–38]. However, these findings
were not echoed in the human NP cell viability, which
showed little changewhen nutritionwas altered.We have also
includedmore culture conditions/combinations, for example,
high glucose. There are numerous differences between the
current study and our previous reported observations [29,
35], the most obvious and significant difference being that
in the current study we are also comparing cells isolated
from human disc (in addition to bovine) and human bone
marrow; the manner in which these human cell populations
respond to their environmental conditions is obviously very
relevant to their use in developing cellular treatments for disc
degeneration and in clinical trials. In addition, we have built
on our previous work, when we assessed cells’ response to
nutrient deprivation at only an end time point [29], by using
a very different state-of-the-art methodology (continuous
temporal analysis). The live cell imaging techniques used in
the current study havemade the detailed longitudinal analysis
of cellular responses to altered nutrition possible and have
shown, forwhatwe believe is the first time, that disc cells show
an initial response to changes in levels of FBS and glucose but
then are apparently able to adapt. Through these temporal
analyses, we have shown that human NP cells undergo
an initial loss of adherence in response to glucose deprivation,
appearing temporarily rounded and phase-bright, but, in the
presence of FBS, recover quickly (within 48 hours) to return
to a fibroblast-like morphology, at least in monolayer. These
transient observations would otherwise have been missed
with end point analysis or would have required intermit-
tent exposure to suboptimal culture conditions for manual
image capture and labour intensive quantitation of culture
parameters. These potentially important temporal findings
are perhaps reflective of the reduced glucose required by
NP cells for maintenance of focal adhesions [39], compared
to the other cells tested. This suggests the ability of human
NP cells not only to survive glucose deprivation, but also to
actively recover following exposure to glucose-poormedium.
The resilience to reduced nutrition observed in the human
NP cultures may reflect the poor environment from which
they have originated, that is, the degenerate human IVD,
and perhaps is indicative of “hormesis,” where the exposure
of cells to mild doses of stressors induces a response that
increases stress resistance (i.e., “that which does not kill
us makes us stronger”) [40]. Additionally, their recovery
may be indicative of NP cells switching to using glycogen
stores for an energy source, following the removal of glucose
in the culture medium. Indeed, a previous study reported
that complete glucose starvation only eliminated lactate
production (a commonly used measure of metabolism) after
2 days of exposure [34], possibly following the depletion of
glycogen stores which are known to exist in up to 70% of cells
from surgically obtained IVDs [24]. Hence, these cells may
have developedmechanisms to survive the increasingly harsh
environments of the degenerate IVDwhichmay explain their
increased ability to withstand a nutritional insult in vitro (i.e.,
no glucose).
Although they are more indifferent to nutrient assault
than MSCs, we have demonstrated that NP cells can be
induced to undergo cell death, and specifically apoptosis,
via H
2
O
2
and staurosporine application, resulting in rapid
NP cell shrinkage, decrease in cell number, and, for stau-
rosporine, cell fragmentation. These changes occurred at a
markedly faster rate following H
2
O
2
treatment compared to
staurosporine. It appears that staurosporine and hydrogen
peroxide lead to cell death via different mechanisms. Acti-
vation of the ERK pathway is the result in cells exposed to
hydrogen peroxide [41], whereas staurosporine causes cell
death via the release of Cathepsin D from the lysosomes, an
event which is independent of oxidative events. In addition,
the timescale appears different, with a short insult of one
hour’s exposure to staurosporine producing cell death over
the subsequent 24 hours [41].
We have also attempted to quantitate changes in cell area
in response to changes in the amount of FBS and altered levels
of glucose. It should be noted that the cell area assessed here
is purely a measure of two-dimensional cell spreading and
does not take into account any cellular changes in the 𝑧-axis.
Hence, a reduction in cell area may not reflect a reduction in
cell volume. Nonetheless, we have shown that the cell area of
bovine NP cells was markedly reduced by FBS and glucose
deprivation compared to those cells supplemented with any
level of FBS or glucose, consistent with the cell shrinkage
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and phase-bright morphology seen. However, no significant
differences in cell area were noted in either human NP or
MSC cultures in any of the nutrient conditions assessed.
Those reductions in area that have been noted for bovine NP
cells may indicate that these cells are in the process of dying
in response to nutrient starvation. Alternatively, or perhaps
coincidentally, cells may be spreading (indicative of in vitro
dedifferentiation or hypertrophy) in the presence of FBS or
glucose supplementation [42, 43]. Further investigation is
required to corroborate these hypotheses. Cell spreadingmay
be indicative of the cells’ propensity for adherence to the
tissue matrix in vivo, although cells may attach differently to
the tissue culture plastics in vitro than to collagen fibres, for
example, in vivo.
It is noteworthy that none of the FBS and glucose combi-
nations tested here resulted in a reduction in live cell number
in either bovine or humanNP cultures or humanMSCs in the
culture systems studied. However, FBS and glucose starvation
was shown to reduce cell proliferation. Previous studies
support these findings, reporting that FBS deprivation in NP
cultures resulted in reduced cell proliferation and growth
arrest, but not an increase in cell death [35]. Indeed, Risbud
et al. [44] reported that NP cells actively resist apoptosis
following FBS deprivation, via the upregulation of PI3K/Akt
and MEK/ERK signalling pathways. Our results appear to
show the ability of cells to survive in environments of reduced
nutrition, although we have not examined the influence of
serum starvation and reduced glucose on alterations in cell
phenotype. Omlor et al. [45] showed that reduced levels of
glucose resulted in significantly reducedmetabolic activity in
porcine intervertebral disc cells, whilst reduction of glucose
(to 0.45 g/L) in human MSCs has been shown to prevent
cellular senescence yet increase proliferative abilities [46]. In
other cell types, such as muscle cells, the introduction of high
glucose has been shown to inhibit apoptosis normally caused
by deprivation of FBS [47]. Further, it has recently been
reported thatMSCs have an immunomodulatorymechanism
of action, via paracrine secretions [48]; therefore, the length
of their survival in the nutrient-poor environment of the NP
may not need to be long to produce an effect.
We realise that there are limitations to our study, in that
we have only assessed cell survival via temporal morphologi-
cal changes in monolayer culture. The study could have been
improved in several ways, for example, by examining how the
environment affected the actual functioning of the cells, not
only if grown in low nutrient levels but also if grown under
hypoxic conditions as can be found in the disc matrix. These
further studies would be of benefit and relevance to use of
these cells as a therapy for the restoration of the degenerate
IVD.
5. Conclusions
This study demonstrates that NP cells and MSC react tem-
porally to alterations in their nutrient environment in vitro.
Specifically, bovine NP cells proliferate less and become
smaller in terms of area in response to FBS and glucose depri-
vation. Human MSC showed similar sensitivity to nutrient
deprivation in terms of growth arrest, but not cell area, whilst
human NP cells appeared to remain unresponsive to nutrient
change in any of the conditions tested or culture parameters
analysed. However, there is no evidence that FBS or glucose
starvation could initiate cell death in these cultures; in fact,
this is only seen following the direct application of toxic
stimuli. These findings suggest that human NP cells and
MSC could be tolerant to nutrient-poor conditions andmight
survive if implanted into degenerate IVD tissue. The results
of this study may therefore have implications, not only for
the understanding of IVD cell biology and pathology, but also
perhaps for the development of cell therapy strategies.
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